Too Early to Abandon Convalescent Plasma for Supportive Treatment of COVID-19
Transfus Med Hemother
.
2023 Apr 3;50(3):256-258.
doi: 10.1159/000530097.
eCollection 2023 Jun.
Authors
Rainer Seitz
1
,
Lutz Gürtler
2
,
Ute Vahlensieck
1
,
Anneliese Hilger
1
,
Wolfgang Schramm
3
Affiliations
1
Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines, Langen, Germany.
2
Max von Pettenkofer Institut, Ludwig-Maximilians University (LMU), Munich, Germany.
3
Ludwig-Maximilians University (LMU) and Rudolf Marx Stiftung, Munich, Germany.
PMID:
38306192
PMCID:
PMC10826597
DOI:
10.1159/000530097
No abstract available
Grants and funding
Authors received no funding in the preparation of the manuscript.